LRRK2-Targeting Therapies March Through the Valley of Death.
Publication
, Journal Article
West, AB; Schwarzschild, MA
Published in: Mov Disord
March 2023
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Mov Disord
DOI
EISSN
1531-8257
Publication Date
March 2023
Volume
38
Issue
3
Start / End Page
361 / 365
Location
United States
Related Subject Headings
- Neurology & Neurosurgery
- Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
- Humans
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1106 Human Movement and Sports Sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
West, A. B., & Schwarzschild, M. A. (2023). LRRK2-Targeting Therapies March Through the Valley of Death. Mov Disord, 38(3), 361–365. https://doi.org/10.1002/mds.29343
West, Andrew B., and Michael A. Schwarzschild. “LRRK2-Targeting Therapies March Through the Valley of Death.” Mov Disord 38, no. 3 (March 2023): 361–65. https://doi.org/10.1002/mds.29343.
West AB, Schwarzschild MA. LRRK2-Targeting Therapies March Through the Valley of Death. Mov Disord. 2023 Mar;38(3):361–5.
West, Andrew B., and Michael A. Schwarzschild. “LRRK2-Targeting Therapies March Through the Valley of Death.” Mov Disord, vol. 38, no. 3, Mar. 2023, pp. 361–65. Pubmed, doi:10.1002/mds.29343.
West AB, Schwarzschild MA. LRRK2-Targeting Therapies March Through the Valley of Death. Mov Disord. 2023 Mar;38(3):361–365.
Published In
Mov Disord
DOI
EISSN
1531-8257
Publication Date
March 2023
Volume
38
Issue
3
Start / End Page
361 / 365
Location
United States
Related Subject Headings
- Neurology & Neurosurgery
- Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
- Humans
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1106 Human Movement and Sports Sciences
- 1103 Clinical Sciences